Image

Spanish Series of Patients Treated With the Radionuclide Lutetium177

Study of Investigational Medication in Treating Somatostatin Receptor Positive Tumors

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates somatostatin receptor positive tumors. It focuses on understanding how the treatment with Lutetium-177 works in these conditions.

The study evaluates the safety, tolerance, and effectiveness of Lutetium-177 in routine clinical practice. It looks at patient and tumor profiles and their treatment outcomes.

  • Who can participate: Adults aged 18 and older with unresectable or metastatic, progressive, somatostatin receptor positive tumors can participate. Written informed consent is required.
  • Study details: Participants' medical records will be reviewed to collect data after obtaining consent. The study will look at the outcomes of patients treated with investigational medication.
Print
Study details
    Neuroendocrine Tumors
    Intestinal Neoplasms
    Pancreatic Neoplasms
    Stomach Neoplasms
    Neuroectodermal Tumors
    Neoplasms
    Germ Cell and Embryonal
    Neoplasms by Histologic Type
    Neoplasms
    Neoplasms
    Nerve Tissue
    Gastrointestinal Neoplasms
    Digestive System Neoplasms
    Neoplasms by Site
    Endocrine Gland Neoplasms
    Digestive System Diseases
    Gastrointestinal Disease
    Intestinal Diseases
    Pancreatic Disease
    Endocrine System Diseases

NCT04949282

Sociedad Española de Medicina Nuclear e Imagen Molecular

8 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.